Picture of Vetoquinol SA logo

VETO — Vetoquinol SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

France's Vetoquinol H1 net income rises on US sales growth, strong Essentials products demand

France's Vetoquinol H1 net income rises on US sales growth, strong Essentials products demand


Overview

  • France animal health firm's H1 sales grew 0.7% on reported basis, 3.4% at constant rates

  • Net income for H1 2026 rose 21.8% yr/yr to 11.8% of sales

  • Company's growth driven by Essential products and strong U.S. market performance


Outlook

  • Vetoquinol did not provide specific financial guidance or outlook for future periods


Result Drivers

  • ESSENTIALS PRODUCTS - Growth in Essentials products, which now account for two-thirds of sales, supported overall business performance

  • U.S. MARKET - Strong sales growth in the U.S., up 13.1% in USD, was a key driver for the half-year

  • PRODUCT MIX AND PRICING - Higher gross margin attributed to increased share of Essentials products and price rises of over 2.5%


Company press release: ID:nBw4rVkpfa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

H1 Sales

EUR 259.30 mln

H1 Net Income

EUR 30.50 mln

H1 EBIT

EUR 39.20 mln

H1 EBITDA

EUR 53.90 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the pharmaceuticals peer group is "buy"

  • Wall Street's median 12-month price target for Vetoquinol SA is €81.50, about 22.6% above its September 9 closing price of €66.50

  • The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 14 three months ago


Reuters Recommended Reads

  • Sept 9 - French medical device maker SpineGuard's H1 loss widens on US sales model shift

  • Sept 9 - France's Séché Environnement H1 revenue rises on international acquisitions

  • Sept 9 - French digital service firm Neurones H1 profit up 16.4%


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Vetoquinol SA

See all news